- ASSISTANT PROFESSOR Radiation Oncology
MD, Duke University
Residency, Internal Medicine
NYU Medical Center
Residency, Radiation Oncology
Mount Sinai Hospital
- Seth Blacksburg M.D., M.B.A., is a board certified radiation oncologist with specialized training in the treatment of Genitourinary, Gastrointestinal, and Central Nervous System tumors with innovative radiation techniques including Brachytherapy, Image Guided Radiation Therapy (IGRT), Stereotactic Radiosurgery (SRS), and Stereotactic Body Radiation Therapy (SBRT). The goals of these therapies are to maximally treat and cure cancer while minimizing radiation side effects to adjacent tissues.
Dr. Blacksburg completed his medical training at the Duke University School of Medicine, where he also received a Masters of Business Administration with a concentration in Health Sector Management. He completed his medical internship at New York University School of Medicine and completed his residency in radiation oncology at the Mount Sinai Icahn School of Medicine. Dr. Blacksburg served as chief resident for two years during this time. A pioneer in using medical informatics to enhance quality treatment in radiation oncology, he was selected to serve as a Clinical Quality Fellow by the Greater New York Hospital Association (GNYH) and the United Hospital Fund (UHF).
Dr. Blacksburg’s research interests include exploring the role of novel radiation therapeutic modalities to improve cancer cure rates and minimize side effects in patients with prostate cancer, brain and spinal cancers, and hepatobiliary malignancy. To that end, he has expertise in the use of brachytherapy, image guided radiation, and stereotactic therapy for treating patients. He is an innovator in the field of medical informatics and continues to refine novel approaches to enhance patient safety. Dr. Blacksburg has published his experience with these treatments.
Dr. Blacksburg is a member of the American Society for Radiation Oncology (ASTRO) and the American Medical Association.
Patients’ Choice Award
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Blacksburg did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Kravis Children Floor 1st Floor
1184 Fifth Avenue
New York, NY 10029
1184 Fifth Avenue
New York, NY 10029
- Monday 9:00am - 5:00am
- Tuesday 9:00am - 5:00am
- Wednesday 9:00am - 5:00am
- Thursday 9:00am - 5:00am
- Friday 9:00am - 5:00am